Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal...

Hospira Announces New Contract With MedAssets for Intravenous Solutions,
Renewal of Infusion Devices Agreement

LAKE FOREST, Ill., June 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:
HSP), a global specialty pharmaceutical and medication delivery company, today
announced agreements with MedAssets on intravenous (I.V.) solutions and
gravity I.V. equipment, and a renewal of its agreement for infusion devices.
The five-year MedAssets agreements are effective as of June 1, 2009, for I.V.
solutions and equipment, and July 1, 2009, for infusion devices. These new
agreements represent a first for Hospira from a contract award position on
I.V. solutions and gravity I.V. equipment.

"MedAssets shares Hospira's commitment to improving patient and healthcare
safety, as well as finding ways to reduce the high costs of healthcare," said
Pete Baker, vice president and general manager, Commercial Service Operations,
Hospira. "We look forward to continuing our work with MedAssets' member
healthcare institutions to drive these goals."

The agreements, all of which run through June 30, 2014, are multi-source
awards. They include Hospira's general-purpose medication management
technologies, such as the Plum A+(R) device; the next-generation Symbiq(R)
infusion system with Hospira MedNet(R) safety software; and pain management
pumps, such as the LifeCare PCA(R) device with Hospira MedNet(R) safety
software, and GemStar(R) ambulatory devices. These products play a critical
role in improving patient safety as well as enhancing quality of care and
clinician workflow. Also covered within the agreements is access to contracts
for Hospira's I.V. solutions, including the company's environmentally
preferable VisIV(R) container, and the IV solutions' associated equipment
portfolio.

"We are pleased to expand our relationship with Hospira," said Mark Miriani,
president of MedAssets Supply Chain Systems. "Adding Hospira's full line of
I.V. solutions and gravity I.V. equipment to our existing portfolio provides
additional options for our members as part of our flexible, customer-driven
approach to reducing supply expenses for our members."

About MedAssets

MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their
financial strength by implementing spend management and revenue cycle
solutions that help control cost, improve margins and cash flow, increase
regulatory compliance, and optimize operational efficiency. MedAssets serves
more than 125 health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers. For more information, visit www.medassets.com.

About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery
company dedicated to Advancing Wellness(TM). As the world leader in specialty
generic injectable pharmaceuticals, Hospira offers one of the broadest
portfolios of generic acute-care and oncology injectables, as well as
integrated infusion therapy and medication management solutions. Through its
products, Hospira helps improve the safety, cost and productivity of patient
care. The company is headquartered in Lake Forest, Ill., and has more than
14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.

Media, Daniel Rosenberg, +1-224-212-3366, or Financial Community, Karen King,
+1-224-212-2711, both of Hospira, Inc.